Arimidex, Anastrozole News

Breast Cancer Home > Dr. switching arimidex to tomoxifen. Featured Content Radiation FAQs Dr.

Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors.

At AstraZeneca, we're committed to helping women with breast cancer get treatment and support.

A $17.5 million preliminary settlement has been reached in a lawsuit alleging severe flaws in a Canadian health care provider's breast cancer screening.

Cancer patient pleads for health reform Please hear the voice of a cancer patient who may not be able to afford the medication that will keep her cancer from returning.

National Breast Cancer Awareness Month debuted in 1985 with the intention of encouraging women to get a mammogram for early detection of the disease.

The U.S. Anti-Doping Agency announced Tuesday that Houston-based Category 1 racer Mitch Comardo has been suspended for two years after testing positive for several prohibited substances.

Breast Cancer Home > Questions > Comments on carboplatin/taxotere w/herceptin. Option of combo w/Avastin Comments on carboplatin/taxotere w/herceptin. Option of combo w/Avastin Diagnosed 2 weeks ago, IDC, surgery 1 week ago .

A woman looks at a mammogram. Despite the leaps and bounds that have been made in early detection and breast cancer treatment, a breast cancer diagnosis is still a terrifying thing to face.

Hormone therapy is a treatment option for women with early-stage, hormone-sensitive breast cancer, identified by the presence of hormone receptors.

Paclitaxel - is a cancer chemo drug that works by slowing or stopping cancer cell growth.

This entry marks exactly one year of my blog. For those who have been with me all the way, thank you for reading and I hope it has been of some help to you.

In my last column, , I described how and why I believe the American Cancer Society misleads women into believing that eating soy on a regular basis is useless as a natural way to prevent breast cancer.

A recent study published in the International Journal of Cancer found evidence supporting that mushrooms have breast cancer-fighting properties.

Background:Acquired resistance to endocrine therapy in breast cancer is poorly understood.

Treatment of postmenopausal breast cancer with an aromatase inhibitor increases the risk of developing carpal tunnel syndrome , although cases are mild to moderate and do not lead to patients stopping treatment, according to a study published online Sept.

In my last column I wrote about the overwhelming amount of research that shows how soy, especially fermented soy, protects against breast cancer.

The high incidence of these tumor types translates into a significant commercial potential for drug developers.

High-dose fulvestrant, an estrogen receptor antagonist, appears to be at least as effective as the aromatase inhibitor anastrozole as a first-line endocrine therapy in postmenopausal women with advanced hormone receptor-positive breast cancer, according to research published online Aug.

Aug. 19, 2009 -- Breast cancer patients may do as well with the drug Femara as they do with tamoxifen , a new study shows.